Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...

Principals largely said they want to get better at helping their teachers succeed, improving their own work-life balance, and ...

Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 ...

Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...

In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...

Reports 5.2% Increase in NII Per Share and 0.7% Increase in NAV from Previous Quarter, with NAV Per Share Remaining Stable ...

Detailed price information for Onestream Inc Cl A (OS-Q) from The Globe and Mail including charting and trades.

Olema Pharmaceuticals (OLMA) earns a "Strong Buy" rating, driven by advancing palazestrant for 1st-line ER+/HER2- metastatic breast cancer in pivotal phase 3 trials.

Domestic players must adapt agilely and effectively to a noticeable shift in segment-specific consumer behavior amid weaker ...

At the 2026 renewals, ceding commissions on quota share business moved up by 1%-1.5%, with most commissions now in the ...

LG Display, the world's leading innovator of display technologies, will showcase a full lineup of strategic OLED products built on its world-leading ...